Skip to content

Ultrafast ultrasonic COMpound Push wave imAging and Strain eStimation (Ultra-COMPASS) for individual plaque stratification in the carotid arteries

Ultrafast ultrasonic COMpound Push wave imAging and Strain eStimation (Ultra-COMPASS) for individual plaque stratification in the carotid arteries - Ultra-COMPASS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51016
Enrollment
Unknown
Registered
2021-08-18
Start date
2021-11-19
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriosclerosis carotid arteries

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Ischemic stroke or transient ischemic attack in anterior flow area - Opportunity to undergo Ultra-COMPASS ultrasound measurements *7 days after initiation of first clinical symptoms - Stenosis 30-70% of carotid arteries based on clinically performed carotid ultrasound or thickening of at least 2mm on CT/MR scan - *18 jaar - Informed consent

Exclusion criteria

Exclusion criteria: - Total occlusion common carotid artery or internal carotid artery - Cardio-embolic nature of ischemic stroke (a.o. atrial fibrilation, valvular prothesis, endocarditis, recent myocardial infarction) - Restenosis after carotid endarterectomy - Acute myocardial infarction - Radiotherapy-induced carotid stenosis

Design outcomes

Primary

MeasureTime frame
Change in plaque composition (= change in plaque stiffness) measured with Ultra-COMPASS measurements

Secondary

MeasureTime frame
- Determine the association between (changes in) Ultra-COMPASS measurements and the lipid-lowering drugs used 6 and 12 weeks after ischemic stroke. - Determine the association between Ultra-COMPASS measurements and recurrent cardiovascular events (TIA / cerebral infarction / myocardial infarction/death) 6 and 12 weeks after ischemic stroke. - Determine the association between Ultra-COMPASS measurements and (changes in) low-density lipoprotein levels 6 and 12 weeks after ischemic stroke (if known).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)